News | March 14, 2023
Pfizer acquires Seagen for US$ 43 billion to battle cancer
Proposed combination enhances Pfizer’s position as a leading company in oncology
Proposed combination enhances Pfizer’s position as a leading company in oncology
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
Submissions based on favorable MagnetisMM-3 trial results in patients with relapsed or refractory multiple myeloma
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
Subscribe To Our Newsletter & Stay Updated
